Stock Analysis · Healthpeak Properties Inc (DOC)
Overview
Healthpeak Properties Inc is a real estate investment trust, or REIT, focused on healthcare real estate. In simple terms, it owns specialized buildings and collects rent from tenants that operate in healthcare-related fields. After its combination with Physicians Realty Trust, the company became more concentrated in outpatient medical buildings while still keeping meaningful exposure to life science laboratories and senior housing.
Its portfolio is built around properties that tend to be tied to long-term healthcare demand rather than traditional office or retail cycles. That matters because aging demographics, steady medical use, and the need for specialized facilities can make healthcare real estate more durable than many other property categories.
The company’s main revenue sources are broadly organized by property type. Based on recent company reporting, the mix is approximately:
- Outpatient medical buildings: about 50% to 55% of revenue. These are buildings near hospitals or in community settings used by physicians, clinics, and other ambulatory care providers.
- Life science properties: about 25% to 30% of revenue. These are lab and research buildings leased to biotechnology, pharmaceutical, and related tenants.
- Continuing care retirement community and senior housing interests: about 15% to 20% of revenue. This includes housing and care-oriented communities serving older adults, often through operating or structured real estate arrangements.
- Other items: a small remainder, including interest income and other property-related sources.
The broad pattern over the last several years has been rising revenue, but with pressure on interest expense and bottom-line profit. Revenue expanded from roughly $1.9 billion in 2021 to above $2.8 billion in 2025, while net income became much more volatile. That suggests the asset base has grown, but financing costs and portfolio shifts have made earnings less smooth.
The business mix shows a larger revenue base than a few years ago, but the flow from revenue to final profit has become less efficient. Interest costs have moved up materially, which is an important theme for a property owner that relies on debt and capital markets.
Key Figures
| Metric | Value | Sector ⓘ |
|---|---|---|
| Date | Oct 24, 2026 | |
| Context | ||
| Sector | Real Estate | |
| Industry | REIT - Healthcare Facilities | |
| Market Cap ⓘ | $13.10B | |
| Beta ⓘ | 0.99 | |
Value (Cheapness) | ||
| P/E Ratio ⓘ | 52.80 | 17.85 |
| P/B Ratio ⓘ | 2.16 | 0.87 |
| FCF Yield ⓘ | 2.26% | 7.30% |
| Dividend Yield ⓘ | 6.50% | 4.83% |
| EBIT / EV ⓘ | 3.00% | 3.78% |
| PEG ⓘ | 4.08 | |
Growth (Business expansion) | ||
| Revenue Growth ⓘ | 11.10% | 5.35% |
| RPS Growth (5Y CAGR) ⓘ | 3.63% | 6.02% |
| EPS Growth (5Y CAGR) ⓘ | 23.06% | -10.65% |
| BVPS Growth (5Y CAGR) ⓘ | -5.53% | 0.43% |
| Margin Growth (5Y Trend) ⓘ | -0.38% | -0.69% |
| FCF Growth (5Y CAGR) ⓘ | 12.01% | 5.40% |
| DPS Growth (5Y CAGR) ⓘ | 0.30% | 5.07% |
Quality (Business durability) | ||
| ROIC (Latest) ⓘ | 3.69% | 5.69% |
| ROE (Latest) ⓘ | 3.86% | 7.37% |
| ROA (Latest) ⓘ | 1.23% | 2.85% |
| ROIC (5Y Median) ⓘ | 3.59% | 4.26% |
| ROE (5Y Median) ⓘ | 5.16% | 6.04% |
| ROA (5Y Median) ⓘ | 1.94% | 2.45% |
| Net Debt / EBIT (Latest) ⓘ | 12.69 | 7.55 |
| Net Debt / EBIT (5Y Median) ⓘ | 16.08 | 8.26 |
| Net Debt / EBITDA (Latest) ⓘ | 4.98 | 5.26 |
| Net Debt / Assets ⓘ | 40.10% | 37.45% |
| EBITDA / Interest ⓘ | 5.18 | 4.11 |
| Operating Margin (Latest) ⓘ | 23.23% | 33.86% |
| Operating Margin (5Y Median) ⓘ | 20.50% | 37.49% |
| Debt to Equity (Latest) ⓘ | 131.56% | 88.76% |
| Profit Margin (Latest) ⓘ | 8.25% | 18.94% |
| Free Cash Flow (Latest) ⓘ | $296.21M | |
Momentum (Price trend) | ||
| 3Y Return ⓘ | +43.11% | +36.33% |
| 12M Return (excl. last month) ⓘ | +18.98% | +4.32% |
| 6M Return ⓘ | +22.05% | -1.74% |
| Price vs. 200-Day MA ⓘ | +3.96% | -1.42% |
Healthpeak is a large healthcare REIT with a market value in the mid-teens of billions of dollars and a share-price volatility close to the broader market. The overall picture is mixed. On valuation metrics, the shares screen richer than the sector median, especially on earnings and book value. On growth, recent revenue growth has been strong, but longer-term revenue-per-share growth has been modest relative to peers. On quality, profitability ratios sit below sector medians, while leverage is not extreme for a REIT but remains meaningful. On momentum, the stock has recently outperformed much of the sector, which shows improving market sentiment.
Growth
Healthpeak operates in a part of real estate that benefits from structural demand. The healthcare sector is supported by an aging U.S. population, continued growth in outpatient care, and steady demand for advanced laboratory space tied to drug development and medical research. Those are long-duration drivers rather than short-lived trends.
The company’s strategy also makes sense from a portfolio-construction angle. Outpatient medical buildings usually offer recurring rent from physician groups and health systems, while life science buildings can command premium rents because they require specialized infrastructure. This combination gives Healthpeak exposure to both defensive healthcare use and higher-value research space.
A major strategic change was the merger with Physicians Realty Trust, which increased scale in outpatient medical real estate. That deal made the portfolio more focused and gave the company a larger presence in a property type with durable occupancy characteristics. In practice, this can help create better tenant diversification, stronger relationships with health systems, and more redevelopment or leasing opportunities across the combined footprint.
Revenue per share has moved up over the past five years, but the pace has been moderate rather than exceptional. That suggests the company has grown, though part of the expansion has been offset by the larger share count that often comes with REIT acquisitions and capital raising.
The dividend per share has been broadly stable, with only limited growth over time. For a healthcare REIT, that points to a business that is still producing enough cash to maintain distributions, but not one that has recently translated growth into consistently faster dividend increases.
One current catalyst is the possibility of a more supportive financing environment if interest rates stabilize or decline. REITs are highly sensitive to borrowing costs, and Healthpeak’s earnings profile would likely benefit if refinancing becomes cheaper. Another catalyst is leasing execution in life science properties, where improved demand and occupancy can have an outsized effect on returns because these assets tend to carry higher rent levels than standard medical office buildings.
Recent company updates have also emphasized portfolio simplification, capital recycling, and operating discipline. Those moves matter because they can improve asset quality over time even if headline growth looks modest in any single quarter.
Risks
This article is for informational purposes only and does not constitute financial advice. Some content is AI-generated. See Disclaimer